News & Events
-
-
Press Announcements
-
-
Sign up to receive FDA Press Releases.
Note: Some links in press announcements are no longer active, but remain for archival purposes. For more information, contact the FDA's Press Office at 301-796-4540.
August 2006
- August 30, 2006 - FDA Warns Consumers Not to Buy or Use Prescription Drugs from Various Canadian Websites that Apparently Sell Counterfeit Products
- August 30, 2006 - FDA Forms Task Force on Human Tissue Safety
- August 29, 2006 - FDA Takes Close Look at Experience Gained from Regulations Allowing Emergency Research With An Exception from Informed Consent Requirements
- August 28, 2006 - FDA Approves First Generic Ciprofloxacin Injection, USP
- August 24, 2006 - FDA Approves Over-the-Counter Access for Plan B for Women 18 and Older
- August 24, 2006 - United States Marshals Seize Defective Infusion Pumps Made by Alaris Products
- August 23, 2006 - FDA Proposes New Rule to Automate Drug Registration and Listing
- August 21, 2006 - FDA Statement on Tenth Circuit's Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
- August 18, 2006 - FDA Orders Donor Referral Services and Philip Guyett to Cease Manufacturing Human Cells, Tissues and Cellular and Tissue-Based Products (HCT/Ps) and to Retain HCT/Ps
- August 17, 2006 - FDA Notifies Consumers of Restitution Program for Purchases of Lane Labs' Products
- August 17, 2006 - FDA Approves New Medical Use for Plavix
- August 11, 2006 - FDA Updates Consumer Advisory to Avoid Certain Raw Shellfish from the Pacific Northwest
- August 10, 2006 - Journal of American Medical Association article on Recalls and Safety Alerts Affecting Automated External Defibrillators
- August 10, 2006 - FDA Warns Three Pharmacies To Stop Mass-Producing Unapproved Inhalation Drugs
- August 09, 2006 - FDA Forms Internal Nanotechnology Task Force
- August 09, 2006 - FDA Seeking Comments on Use of Identifier System for Medical Devices
- August 08, 2006 - FDA Approves First Generic Venlafaxine
- August 03, 2006 - FDA's National Center for Toxicological Research Publishes Study on Distinguishing Potential Hoax Materials from Bioterror Agents
- August 02, 2006 - FDA Approves Influenza Vaccines To Be Manufactured for Upcoming Flu Season
July 2006
- July 31, 2006 - Consumers Advised To Avoid Raw Oysters From the Pacific Northwest
- July 31, 2006 - FDA Announces Framework for Moving Emergency Contraception Medication to Over-the-Counter Status
- July 27, 2006 - FDA Warns Consumers Against Drinking High-Strength Hydrogen Peroxide for Medicinal Use
- July 24, 2006 - FDA Approves a New Over-the-Counter Sunscreen Product
- July 24, 2006 - FDA Approves First Treatment for Hunter Syndrome
- July 24, 2006 - FDA Announces Plan to Strengthen Advisory Committee Processes
- July 24, 2006 - FDA Approves Oncaspar for Newly-Diagnosed Acute Lymphoblastic Leukemia
- July 21, 2006 - FDA Warns Consumers and Health Care Providers Not to Use Bismacine, also known as Chromacine
- July 20, 2006 - FDA Statement on Institute of Medicine's Report on Preventing Medication Errors
- July 20, 2006 - FDA Names First Medical Director for Emerging and Pandemic Threat Preparedness in the Center for Biologics Evaluation and Research
- July 19, 2006 - FDA Approves First Generic Meloxicam
- July 18, 2006 - FDA Approves the First Fully Automated Screening and Confirmatory Tests for Hepatitis B Surface Antigen
- July 13, 2006 - FDA Statement on Blood Product Advisory Committee Meeting on Proposed Clinical Trial for Blood Substitute Product
- July 12, 2006 - FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement
- July 12, 2006 - FDA Approves the First Once-a Day Three-Drug Combination Tablet for Treatment of HIV-1
- July 11, 2006 - FDA Update Statement on Boston Scientific/Guidant Pacemakers and Defibrillators
June 2006
- June 30, 2006 - FDA Approves First Generic Sertraline
- June 30, 2006 - FDA Commemorates a Century of Protecting and Promoting Public Health
- June 30, 2006 - FDA Approves New Biologic Treatment for Wet Age-Related Macular Degeneration
- June 30, 2006 - FDA Grants Tentative Approval of a Three-Component AIDS Drug In Association with the President's Emergency Plan for AIDS Relief
- June 29, 2006 - FDA Completes Safety Assessment of Ketek New Safety Information to be Added to Product Labeling
- June 29, 2006 - Baxter Healthcare Corp. Signs Consent Decree with FDA; Agrees to Correct Manufacturing Deficiencies
- June 29, 2006 - FDA Gives Rapid Approval for a New Treatment For a Rare Type of Leukemia
- June 27, 2006 - FDA Approves the First Treatment for Dementia of Parkinson's Disease
- June 27, 2006 - FDA Gives Tentative Approval for Another First Time Generic Pediatric AIDS Drug in Association with the President's Emergency Plan for AIDS Relief
- June 26, 2006 - FDA Announces New Initiative to Modernize the Regulation of Clinical Trials and Bioresearch Monitoring
- June 26, 2006 - FDA Statement on Canadian Rule to Control BSE Risks
- June 23, 2006 - FDA Approves First Generic Simvastatin
- June 23, 2006 - FDA Approves New HIV Treatment for Patients Who Do Not Respond to Existing Drugs
- June 21, 2006 - FDA Issues Guidance to Help Prevent Inadvertent Introduction of Allergens or Toxins into the Food and Feed Supply
- June 19, 2006 - FDA Warns Consumers Not to Use Triaminic Vapor Patch
-
-
-
-